[go: up one dir, main page]

AU4672199A - Modulation of angiogenesis and wound healing - Google Patents

Modulation of angiogenesis and wound healing

Info

Publication number
AU4672199A
AU4672199A AU46721/99A AU4672199A AU4672199A AU 4672199 A AU4672199 A AU 4672199A AU 46721/99 A AU46721/99 A AU 46721/99A AU 4672199 A AU4672199 A AU 4672199A AU 4672199 A AU4672199 A AU 4672199A
Authority
AU
Australia
Prior art keywords
angiogenesis
modulation
wound healing
healing
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46721/99A
Inventor
Rocio M. Sierra-Honigmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of AU4672199A publication Critical patent/AU4672199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU46721/99A 1998-05-20 1999-05-20 Modulation of angiogenesis and wound healing Abandoned AU4672199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8635498P 1998-05-20 1998-05-20
US60086354 1998-05-20
PCT/US1999/011209 WO1999059614A1 (en) 1998-05-20 1999-05-20 Modulation of angiogenesis and wound healing

Publications (1)

Publication Number Publication Date
AU4672199A true AU4672199A (en) 1999-12-06

Family

ID=22198042

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46721/99A Abandoned AU4672199A (en) 1998-05-20 1999-05-20 Modulation of angiogenesis and wound healing

Country Status (2)

Country Link
AU (1) AU4672199A (en)
WO (1) WO1999059614A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781390B2 (en) * 1999-09-05 2005-05-19 Yeda Research And Development Co. Ltd. Use of leptin in inhibition of endothelial cell proliferation

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1038755A1 (en) 1999-01-15 2002-03-28 Biogen, Inc. Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
NZ522741A (en) 2000-05-08 2005-06-24 Biogen Idec Inc Method for promoting neovascularization using a TWEAK agonist and an angiogenic factor, such as fibroblast growth factor and VEGF
US7208151B2 (en) 2001-09-12 2007-04-24 Biogen Idec Ma Inc. Tweak receptor agonists as anti-angiogenic agents
US6750234B2 (en) * 2001-03-08 2004-06-15 University Of Kentucky Research Foundation Methods for increasing leptin levels using nicotinic acid compounds
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
MX352180B (en) 2002-04-09 2017-11-13 Biogen Ma Inc Methods for treating tweak-related conditions.
CN101287483B (en) * 2003-08-07 2012-02-29 希尔洛有限公司 Pharmaceutical compositions and methods for accelerating wound healing
DE10353593A1 (en) * 2003-11-17 2005-06-23 Klinikum der Universität München Großhadern-Innenstadt Leptin antagonist and method for the quantitative measurement of leptin
US8043619B2 (en) * 2004-10-08 2011-10-25 Yaron Ilan Methods and uses of leptin in immune modulation
WO2006089095A2 (en) 2005-02-17 2006-08-24 Biogen Idec Ma Inc. Treating neurological disorders
CA2607697C (en) 2005-05-10 2015-01-06 Biogen Idec Ma Inc. Treating and evaluating inflammatory disorders
WO2006138219A2 (en) 2005-06-13 2006-12-28 Biogen Idec Ma Inc. Methods of diagnosis / prognosis of inflammatory conditions
CN120629571A (en) * 2025-06-13 2025-09-12 蚌埠医学院第一附属医院（蚌埠医学院附属肿瘤医院） Use of LEPR gene or protein as a target in the preparation of cholangiocarcinoma therapeutic products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
ES2260784T3 (en) * 1996-01-23 2006-11-01 Indevus Pharmaceuticals, Inc. METHODS OF USE OF THE OBESE GENE AND ITS GENETIC PRODUCT TO STIMULATE HEMATOPOYETIC DEVELOPMENT.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781390B2 (en) * 1999-09-05 2005-05-19 Yeda Research And Development Co. Ltd. Use of leptin in inhibition of endothelial cell proliferation

Also Published As

Publication number Publication date
WO1999059614A9 (en) 2000-06-15
WO1999059614A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AU3191299A (en) Antisense modulation of pecam-1
AU1957697A (en) Methods and compositions for the modulation of cell proliferation and wound healing
GB2313139B (en) Manufacture of trusses
AU4890997A (en) Rayleigh-breakup atomizing devices and methods of making rayleigh-breakup atomizing devices
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU4672199A (en) Modulation of angiogenesis and wound healing
AU5562999A (en) Methods of modulating of angiogenesis
AU1839797A (en) Hyperpolarizable compounds and devices fabricated therefrom
AUPO163696A0 (en) Lighting devices, methods of constructing lighting devices and methods of operating lighting devices
AU3497795A (en) Moist tissue package construction and tissue
AU5929499A (en) A wound treatment composition and a wound dressing containing it
AU1347799A (en) Hydrocolloid wound dressing and the method of making and using the same
AU6620596A (en) Use of transglutaminase modulators to promote wound healing
AU4063197A (en) Antimicrobial medical devices and methods of production and use
AU3274697A (en) Wound healing accelerators
AU6375598A (en) Absorbent wound dressings
AU6045499A (en) Antisense modulation of crel expression
AU2001283486A1 (en) Methods of modulating wound healing and angiogenesis
AU1933297A (en) Manufacture of elongate members
AU4219097A (en) Manufacture of planar waveguide and planar waveguide
AU1853397A (en) Treatment of pulmonary inflammation
GB9608145D0 (en) Wound healing
AU6261199A (en) Antisense modulation of rip-1 expression
AU2823495A (en) Methods and compositions for modulation of wound healing
AU4468597A (en) Improved surgical dressings and method of preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase